Gail H Cassell

Gail H Cassell, Ph.D.

Bio
Research
Publications

Dr. Cassell is vice president for TB Drug Development at the Infectious Disease Research Institute in Seattle, Washington, professor emeritus and former chair, Department of Microbiology, University of Alabama at Birmingham, and former vice president for scientific affairs and distinguished Lilly research scholar for infectious diseases at Eli Lilly and Company in Indianapolis, Indiana. She founded the Forum on Drug Discovery, Development and Translation, which she continues to co-chair, at the Institute of Medicine. She has a distinguished record of national service with the National Academy of Sciences, National Institutes of Health, Centers for Disease Control, and several other national and international institutions.

Affiliations:

Division of Global Health Equity, Brigham and Women's Hospital

Dr. Cassell is a leader on efforts to address multidrug-resistant tuberculosis (MDRTB). She and Barry Bloom, former dean of Harvard School of Public Health, co-lead an Institute of Medicine project on drug supply chain issues related to MDRTB. She actively advises numerous government agencies, NGOs, and foundations on the scale-up of MDRTB diagnosis and treatment in endemic areas around the world, including in Russia. Dr. Cassell is advising the GHSM Sentinel Project on pediatric drug-resistant tuberculosis, a global partnership that aims to develop and deploy evidence-based strategies to prevent child deaths from drug-resistant tuberculosis.

Association of genital mycoplasmas with exudative vaginitis in a 10 year old: a case of misdiagnosis.

Authors: Authors: Waites KB, Brown MB, Stagno S, Schachter J, Greenberg S, Hemstreet GP, Cassell GH.
Pediatrics 1983-02-01
View full abstract on Pubmed

Measurement of antibody to Ureaplasma urealyticum by an enzyme-linked immunosorbent assay and detection of antibody responses in patients with nongonococcal urethritis.

Authors: Authors: Brown MB, Cassell GH, Taylor-Robinson D, Shepard MC.
J Clin Microbiol 1983-02-01
View full abstract on Pubmed

Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16-20 weeks of gestation: potential effect on outcome of pregnancy.

Authors: Authors: Cassell GH, Davis RO, Waites KB, Brown MB, Marriott PA, Stagno S, Davis JK.
Sex Transm Dis 1983-01-01
View full abstract on Pubmed

Antigens of Mycoplasma hominis.

Authors: Authors: Brown MB, Minion FC, Davis JK, Pritchard DG, Cassell GH.
Sex Transm Dis 1983-01-01
View full abstract on Pubmed

Incidence of genital mycoplasmas in women at the time of diagnostic laparoscopy.

Authors: Authors: Cassell GH, Brown MB, Younger JB, Blackwell RF, Davis JK, Marriott P, Stagno S.
Yale J Biol Med 1983-01-01
View full abstract on Pubmed

Murine respiratory mycoplasmosis in F344 and LEW rats: evolution of lesions and lung lymphoid cell populations.

Authors: Authors: Davis JK, Thorp RB, Maddox PA, Brown MB, Cassell GH.
Infect Immun 1982-05-01
View full abstract on Pubmed

Murine respiratory mycoplasmosis in LEW and F344 rats: strain differences in lesion severity.

Authors: Authors: Davis JK, Cassell GH.
Vet Pathol 1982-05-01
View full abstract on Pubmed

Derrick Edward Award Lecture. The pathogenic potential of mycoplasmas: Mycoplasma pulmonis as a model.

Authors: Authors: Cassell GH.
Rev Infect Dis 1982-01-01
View full abstract on Pubmed

Detection of natural Mycoplasma pulmonis infection in rats and mice by an enzyme linked immunosorbent assay (ELISA).

Authors: Authors: Cassell GH, Lindsey JR, Davis JK, Davidson MK, Brown MB, Mayo JG.
Lab Anim Sci 1981-12-01
View full abstract on Pubmed

Comparison of methods for detection of Mycoplasma pulmonis in experimentally and naturally infected rats.

Authors: Authors: Davidson MK, Lindsey JR, Brown MB, Schoeb TR, Cassell GH.
J Clin Microbiol 1981-12-01
View full abstract on Pubmed